Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial.
Qi PanYijun LiHailong WanJunfen WangBinhua XuGuoping WangChengxia JiangLi LiangWei FengJingcheng LiuTing WangXia ZhangNan CuiYi-Ming MuLi-Xin Guonull nullPublished in: Diabetes, obesity & metabolism (2022)
Compared with Asp30 + MET, Gla + 2-3 OADs showed similar efficacy but a lower hypoglycaemia risk in Chinese individuals with type 2 diabetes who had undergone short-term intensive insulin therapy.